ESR/ERS 肺癌筛查声明:证据更新与实践框架
该声明为欧洲放射学会与欧洲呼吸学会联合发布的肺癌筛查专家意见,采用叙述性非系统综述方式汇总筛查试验证据与当前实践。强调高危人群触达、共享决策、基础设施与质量保证、戒烟整合及阳性结果管理,呼吁欧洲卫生系统建立组织化筛查路径并开展示范项目。
要点
- 肺癌筛查应面向高危人群,重视沟通与共享决策。
- 筛查须配套基础设施、标准化路径与质量保证体系。
- 需整合戒烟、辐射最低化、阳性结果与偶发发现管理。
核心结论
- 欧洲卫生系统应建立组织化肺癌筛查路径而非无监督举措,以实现早期诊断并降低死亡率。
- 当前应启动示范项目,聚焦方法学、标准化、戒烟、健康教育、成本效果与中央登记。
研究设计与样本
- 欧洲放射学会与欧洲呼吸学会联合发布的更新版专家意见,为叙述性非系统综述。
- 内容涵盖肺癌筛查试验证据汇总及当前实践描述,并讨论此前未充分关注的方面。
主要发现
- 自2015年首份联合白皮书发布以来,肺癌筛查领域涌现大量新发现且相关讨论显著增加。
- 有效筛查需多学科团队参与,包括呼吸科、放射科、胸科肿瘤、胸外科、病理科、全科医生及患者代表等。
关键数值与推荐
- 筛查关键起始点包括触达潜在参与者(高危人群)、优化沟通与共享决策。
- 基础设施、路径与质量保证标准为核心,涵盖促进戒烟、获益与 harms、过度诊断、质量、最低辐射暴露、阳性筛查结果与偶发发现的管理定义及成本效果。
临床怎么用
- 呼吸科医生应参与多学科筛查团队,推动高危人群识别、共享决策与戒烟整合。
- 在实践中遵循组织化路径与质量标准,关注辐射剂量最低化及阳性结果和偶发发现的规范管理。
局限性
- 本文为叙述性非系统综述,非系统评价,证据汇总方法未按系统综述标准执行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In Europe, lung cancer ranks third among the most common cancers, remaining the biggest killer. Since the publication of the first European Society of Radiology and European Respiratory Society joint white paper on lung cancer screening (LCS) in 2015, many new findings have been published and discussions have increased considerably. Thus, this updated expert opinion represents a narrative, non-systematic review of the evidence from LCS trials and description of the current practice of LCS as well as aspects that have not received adequate attention until now. Reaching out to the potential participants (persons at high risk), optimal communication and shared decision-making will be key starting points. Furthermore, standards for infrastructure, pathways and quality assurance are pivotal, including promoting tobacco cessation, benefits and harms, overdiagnosis, quality, minimum radiation exposure, definition of management of positive screen results and incidental findings linked to respective actions as well as cost-effectiveness. This requires a multidisciplinary team with experts from pulmonology and radiology as well as thoracic oncologists, thoracic surgeons, pathologists, family doctors, patient representatives and others. The ESR and ERS agree that Europe's health systems need to adapt to allow citizens to benefit from organised pathways, rather than unsupervised initiatives, to allow early diagnosis of lung cancer and reduce the mortality rate. Now is the time to set up and conduct demonstration programmes focusing, among other points, on methodology, standardisation, tobacco cessation, education on healthy lifestyle, cost-effectiveness and a central registry.
引用
- Kauczor HU, Baird AM, Blum TG, et al. ESR/ERS statement paper on lung cancer screening. Eur Respir J. 2020. PMID: 32051182. doi:10.1183/13993003.00506-2019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。